Advanced Biomed Inc. cash flow statement

In fiscal 2026, Advanced Biomed Inc.'s operations generated −$1.9m of cash; it spent $0 on capital projects, leaving free cash flow of −$1.9m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Advanced Biomed Inc.: cash flow statement, annual
Fiscal year	2026Jun 2026
Cash from operations	−1,947
Stock-based pay	1,734
Capital spending	0
Free cash flow	−1,947
Free cash flow after stock pay	−3,681
Shares issued	248

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Advanced Biomed Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Advanced Biomed Inc.